ClinicalTrials.govpublic full text
Trastuzumab for HER2 Positive Relapsed/Refractory B-Acute Lymphoblastic Leukemia (B-ALL)
relapsed/refractory leukemia, relapsed/refractory, her2, positive, b-all, trastuzumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807662
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.